PMID: 9542261Jan 1, 1997Paper

Telemedicine in the treatment of diabetic pregnancy

Annali Dell'Istituto Superiore Di Sanità
N di BiaseF Fallucca

Abstract

Good diabetic control requires that treatment be continuously adapted to the patient behavior. We investigated whether the use of telemedicine could present an advantage to the management of the diabetic woman during pregnancy. A system completely automatic (DIANET system) was used. Twenty IDDM women participated in the study: 10 treated by telemedicine and 10 by conventional system, at times "entry" (9.5 weeks), "basal" (9.5-16.8 weeks), "1st month" of investigation, and "end" (near delivery). All women used intensified protocols of insulin administration. The treatment with DIANET vs conventional showed a better metabolic control as estimated by profile of blood glucose absolute values (at time "end": values significantly lower before breakfast: 87 +/- 6 vs 104 +/- 4 mg, lunch: 85 +/- 5 vs 104 +/- 4 mg, and after dinner: 102 +/- 5 vs 124 +/- 6 mg). These results were associated with higher insulin doses in the DIANET vs conventional treatment, and a significant reduction of hypoglycemic reaction in both group. Our results suggest that telemedicine-DIANET is a practical way of providing specialist care in the pregnancy area.

References

Jan 1, 1986·Diabetes Care·T E Adamson, D S Gullion
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert

❮ Previous
Next ❯

Citations

Apr 20, 2012·Diabetes Technology & Therapeutics·Carol J HomkoAlfred A Bove
Nov 27, 2004·Diabetes Research and Clinical Practice·Hyuk-Sang KwonKun-Ho Yoon
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·A FarmerA Neil
Nov 11, 2016·Journal of Medical Internet Research·Wai-Kit MingJane E Hirst
May 24, 2019·The Cochrane Database of Systematic Reviews·Leanne V JonesBrian S Buckley
Nov 7, 2019·American Journal of Therapeutics·Angela Napoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

© 2022 Meta ULC. All rights reserved